Live-attenuated SIV strains provide an important model to study cellular and viral determinants that contribute to disease development and they also provide a unique tool to study mechanisms leading to protective immunity. We focused our work on the viral Rev protein, a key regulatory factor, which is conserved among lentiviruses and is essential for promoting the export of the unspliced and intermediate-spliced mRNAs which encode the structural proteins. We postulated that a drastic change in the posttranscriptional regulation may affect the pathogenicity of HIV and SIV. To test this hypothesis, we found that the Rev-RRE regulation could be replaced by the posttranscriptional control mechanisms of the simian type D retroviruses. SRV expression is mediated via the cellular NXF1 (formerly called TAP) protein, which interacts with the viral RNA transport element CTE. Our demonstration that CTE could replace Rev/RRE in HIV and SIV resulting in production of infectious virus in PBMC opened the way for the evaluation of the pathogenicity of Rev-independent viruses in the presence of all other viral proteins using animal models. Studies from my lab have now demonstrated that changes of the posttranscriptional regulation of HIV and SIV profoundly alters the out-come of the infection. We have evidence from infection of neonatal, juvenile, and adult rhesus macaques that Rev-independent SIV strains lack pathogenicity (von Gegerfelt, A. S., et al. J Virol. 73:6159-6165, 1999; von Gegerfelt, A. S.et al. J Virol: in press 2001). Our data demonstrate that Rev/RRE regulatory mechanism is required for high levels of virus propagation and that this control mechanism plays an important role in the pathogenicity of SIV. The replacement of Rev/RRE by the NXF1/CTE system provides a novel approach to lower the virulence of a pathogenic lentivirus. The availability of non-pathogenic live-attenuated SIV strains provides us with a unique research tool to dissect pathogenic mechanisms leading to AIDS.

Agency
National Institute of Health (NIH)
Institute
Division of Basic Sciences - NCI (NCI)
Type
Intramural Research (Z01)
Project #
1Z01BC010350-02
Application #
6559234
Study Section
(BRL)
Project Start
Project End
Budget Start
Budget End
Support Year
2
Fiscal Year
2001
Total Cost
Indirect Cost
Name
Basic Sciences
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Bergamaschi, Cristina; Jalah, Rashmi; Kulkarni, Viraj et al. (2009) Secretion and biological activity of short signal peptide IL-15 is chaperoned by IL-15 receptor alpha in vivo. J Immunol 183:3064-72
Robinson, T M; Sidhu, M K; Pavlakis, G N et al. (2007) Macaques co-immunized with SIVgag/pol-HIVenv and IL-12 plasmid have increased cellular responses. J Med Primatol 36:276-84
von Gegerfelt, Agneta S; Rosati, Margherita; Alicea, Candido et al. (2007) Long-lasting decrease in viremia in macaques chronically infected with simian immunodeficiency virus SIVmac251 after therapeutic DNA immunization. J Virol 81:1972-9
Egan, Michael A; Megati, Shakuntala; Roopchand, Vidia et al. (2006) Rational design of a plasmid DNA vaccine capable of eliciting cell-mediated immune responses to multiple HIV antigens in mice. Vaccine 24:4510-23
Hel, Zdenek; Tsai, Wen-Po; Tryniszewska, Elzbieta et al. (2006) Improved vaccine protection from simian AIDS by the addition of nonstructural simian immunodeficiency virus genes. J Immunol 176:85-96
Schadeck, Eva B; Sidhu, Maninder; Egan, Michael A et al. (2006) A dose sparing effect by plasmid encoded IL-12 adjuvant on a SIVgag-plasmid DNA vaccine in rhesus macaques. Vaccine 24:4677-87
Kumar, Sanjeev; Yan, Jian; Muthumani, Karuppiah et al. (2006) Immunogenicity testing of a novel engineered HIV-1 envelope gp140 DNA vaccine construct. DNA Cell Biol 25:383-92
von Gegerfelt, Agneta S; Alicea, Candido; Valentin, Antonio et al. (2006) Long lasting control and lack of pathogenicity of the attenuated Rev-independent SIV in rhesus macaques. AIDS Res Hum Retroviruses 22:516-28
Kutzler, Michele A; Robinson, Tara M; Chattergoon, Michael A et al. (2005) Coimmunization with an optimized IL-15 plasmid results in enhanced function and longevity of CD8 T cells that are partially independent of CD4 T cell help. J Immunol 175:112-23
Rosati, Margherita; von Gegerfelt, Agneta; Roth, Patricia et al. (2005) DNA vaccines expressing different forms of simian immunodeficiency virus antigens decrease viremia upon SIVmac251 challenge. J Virol 79:8480-92

Showing the most recent 10 out of 12 publications